glp 1 injections how to use New Guidelines on GLP-1 Drugs for Obesity Released What to do if you

Two other pharmaceutical companies have their own oral GLP-1 drugs in the works: Orforglipron: Developed by Eli Lilly, its in Phase 3 clinical trials for treating type 2 diabetes and obesity, with an expected September 2025 completion

While no specific benefits are officially recognised, this molecule is generating growing interest, opening promising avenues worth further exploration

Includes: (C917) CBC without differential (C901) CMP (C157) TSH (C145) Hemoglobin AIC (C906) Lipid Panel In 4 RCTs, patients (baseline weight 96 to 105 kg) were treated for weight loss with GLP1/GIP medication weekly and lifestyle interventions (counseling, diet, and physical activity)

Thank you in advance for ur respond